Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection

Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection

US Patent 11225482 · Granted Jan 18, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds2025
Heterocyclic compounds2025
Three-degree-of-freedom convenient mobile powder recovery device and recovery me2024
Method for synthesizing lactam derivatives without use of catalyst2024
Heterocyclic compounds2024
Heterocyclic compounds2024
Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disea2023
Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B viru2022
Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B viru2022
Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B viru2022
Imidazole-pyrazole derivatives2022
PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection2021